PRKN and Parkinson disease: They make use of gene variants found in familial forms of PD (e.g., mutations or altered expression levels of synuclein, parkin, PINK1) (Bose et al., 2022; Chia et al., 2020; Program, 2021) and mimic disturbed proteostasis or impaired mitochondrial function.